Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger E Taylor

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2010
Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variablesDavid W Ellison, Mehmet Kocak, James Dalton, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 31, 2009
Impact of radiotherapy parameters on outcome for patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 studyRoger E Taylor, Paul H J Donachie, Claire L Weston, et al.
European Journal of Cancer (Oxford, England : 1990)|April 25, 2006
Analysis of patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 studyBarry L Pizer, Claire L Weston, Kathryn J Robinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 StudyRoger E Taylor, Clifford C Bailey, Kath Robinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2009
Survival after second primary neoplasms of the brain or spinal cord in survivors of childhood cancer: results from the British Childhood Cancer Survivor StudyAliki J Taylor, Clare Frobisher, David W Ellison, et al.
Systematic Reviews|July 28, 2016
The effectiveness and safety of proton beam radiation therapy in children with malignant central nervous system (CNS) tumours: protocol for a systematic reviewCaroline Main, Madhumita Dandapani, Mark Pritchard, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2004
Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastomaRoger E Taylor, Clifford C Bailey, Kathryn J Robinson, et al.
Acta Neuropathologica|January 27, 2011
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroupsDavid W Ellison, James Dalton, Mehmet Kocak, et al.
Acta Neuropathologica|January 8, 2013
DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsiesEdward C Schwalbe, Daniel Williamson, Janet C Lindsey, et al.
Acta Neuropathologica|December 6, 2011
MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastomaSarra L Ryan, Ed C Schwalbe, Michael Cole, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2010
Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variablesDavid W Ellison, Mehmet Kocak, James Dalton, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 31, 2009
Impact of radiotherapy parameters on outcome for patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 studyRoger E Taylor, Paul H J Donachie, Claire L Weston, et al.
European Journal of Cancer (Oxford, England : 1990)|April 25, 2006
Analysis of patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 studyBarry L Pizer, Claire L Weston, Kathryn J Robinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 StudyRoger E Taylor, Clifford C Bailey, Kath Robinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2009
Survival after second primary neoplasms of the brain or spinal cord in survivors of childhood cancer: results from the British Childhood Cancer Survivor StudyAliki J Taylor, Clare Frobisher, David W Ellison, et al.
Systematic Reviews|July 28, 2016
The effectiveness and safety of proton beam radiation therapy in children with malignant central nervous system (CNS) tumours: protocol for a systematic reviewCaroline Main, Madhumita Dandapani, Mark Pritchard, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2004
Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastomaRoger E Taylor, Clifford C Bailey, Kathryn J Robinson, et al.
Acta Neuropathologica|January 27, 2011
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroupsDavid W Ellison, James Dalton, Mehmet Kocak, et al.
Acta Neuropathologica|January 8, 2013
DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsiesEdward C Schwalbe, Daniel Williamson, Janet C Lindsey, et al.
Acta Neuropathologica|December 6, 2011
MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastomaSarra L Ryan, Ed C Schwalbe, Michael Cole, et al.
Pageof 4